HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome.

Abstract
A novel cationic cholesterol derivative-based small interfering RNA (siRNA) interference strategy was suggested to inhibit Notch1 activation in SKOV3 cells for the gene therapy of ovarian cancer. The cationic cholesterol derivative, N-(cholesterylhemisuccinoyl-amino-3-propyl)-N, N-dimethylamine (DMAPA-chems) liposome, was incubated with siRNA at different nitrogen-to-phosphate ratios to form stabilized, near-spherical siRNA/DMAPA-chems nanoparticles with sizes of 100-200 nm and zeta potentials of 40-50 mV. The siRNA/DMAPA-chems nanoparticles protected siRNA from nuclease degradation in 25% fetal bovine serum. The nanoparticles exhibited high cell uptake and Notch1 gene knockdown efficiency in SKOV3 cells at an nitrogen-to-phosphate ratio of 100 and an siRNA concentration of 50 nM. They also inhibited the growth and promoted the apoptosis of SKOV3 cells. These results may provide the potential for using cationic cholesterol derivatives as efficient nonviral siRNA carriers for the suppression of Notch1 activation in ovarian cancer cells.
AuthorsYun-Chun Zhao, Li Zhang, Shi-Sen Feng, Lu Hong, Hai-Li Zheng, Li-Li Chen, Xiao-Ling Zheng, Yi-Qing Ye, Meng-Dan Zhao, Wen-Xi Wang, Cai-Hong Zheng
JournalInternational journal of nanomedicine (Int J Nanomedicine) 2016 Vol. 11 Pg. 5485-5496 ISSN: 1178-2013 [Electronic] New Zealand
PMID27799771 (Publication Type: Journal Article)
Chemical References
  • Arsenicals
  • Cations
  • Liposomes
  • NOTCH1 protein, human
  • RNA, Small Interfering
  • Receptor, Notch1
  • dimethylarsinopenicillamine
  • Cholesterol
Topics
  • Apoptosis (genetics)
  • Arsenicals (chemistry)
  • Cations
  • Cell Line, Tumor (drug effects)
  • Cell Proliferation
  • Cholesterol (analogs & derivatives)
  • Female
  • Gene Silencing
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Humans
  • Liposomes (chemistry)
  • Nanoparticles
  • Ovarian Neoplasms (genetics, pathology)
  • Particle Size
  • RNA, Small Interfering (genetics, metabolism)
  • Receptor, Notch1 (genetics, metabolism)
  • Serum (chemistry)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: